NLS Acquisition

Biohit Oyj and Tianjin Jingsheng Biological Technology Development Co Ltd have signed a distributor agreement for the distribution of the Biohit Calprotectin ELISA test in China. Biohit Calprotectin test is a useful quick test for measuring calprotectin in a stool sample. The test is used to differentiate inflammatory bowel disease (IBD) from irritable bowel syndrome […]

AstraZeneca has decided to acquire all rights to Orexo’s leukotriene C4 synthase inhibitor program (OX-CLI project) for MUSD 5. AstraZeneca established a collaboration with Orexo AB for OX-CLI in 2013 and maintained an option to acquire all rights in the program. As the program has advanced into pre-clinical development with an identified development compound (candidate drug), […]

Swedish medtech company AddLife has acquired V-Tech AB and Esthe-Tech AB. V-Tech markets and sells a product range focusing on surgery, in particular on vascular surgery. It also represents several leading suppliers in its speciality area. Its customers operate mainly in public healthcare in Sweden, Norway and Finland. Esthe-Tech markets and sells specialist products for […]

Genmab has reached a USD 5 million milestone in its daratumumab collaboration with Janssen Biotech, Inc. (Janssen).  This is the second milestone payment triggered by progress in the ongoing Phase II study (“Carina” LYM2001) of daratumumab in NHL. The study evaluates daratumumab monotherapy in three different types of NHL, diffuse large B-cell lymphoma (DLBCL), follicular […]

AstraZeneca has entered into an agreement with ProStrakan Group, a subsidiary of Kyowa Hakko Kirin Co. Ltd., for the rights to Moventig (naloxegol) in the European Union (EU), Iceland, Norway, Switzerland and Liechtenstein. Moventig is the first once-daily, oral peripherally-acting mu-opioid receptor antagonist (PAMORA) approved in Europe for the treatment of opioid-induced constipation (OIC) in […]

Recipharm AB announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialised in the filling of injectable beta lactam products. It is located in Brescia close to Recipharm’s existing operations in Northern Italy. Highlights • Adds […]